Short-Course of Methylprednisolone Improves Respiratory Functional Parameters After 120 Days in Hospitalized COVID-19 Patients (Metcovid Trial): A Randomized Clinical Trial

Background: The use of corticosteroids may help control the cytokine storm occurring in acute respiratory failure due to the severe form of COVID-19. We evaluated the postacute effect of corticosteroids used during the acute phase, such as impairment in pulmonary function parameters, on day 120 (D12...

Descripción completa

Detalles Bibliográficos
Autores principales: Barros, Camila Miriam Suemi Sato, Freire, Raissa Soares, Frota, Elisângela, Rezende Santos, Anna Gabriela, Farias, Maria Eduarda Leão, Rodrigues, Maria Gabriela Almeida, Silva, Bernardo Maia, Prado Jeronimo, Christiane Maria, Netto, Rebeca Linhares Abreu, Silva Borba, Mayla Gabriela, Baía-da-Silva, Djane, Brito-Sousa, José Diego, Xavier, Mariana Simão, Araújo-Alexandre, Marcia Almeida, Sampaio, Vanderson Souza, Melo, Gisely Cardoso, Arêas, Guilherme Tinoco, Hajjar, Ludhmila Abrahão, Monteiro, Wuelton Marcelo, Gomes Naveca, Felipe, Costa, Fábio Trindade Maranhão, Val, Fernando Fonseca Almeida, Lacerda, Marcus Vinícius Guimarães
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8669506/
https://www.ncbi.nlm.nih.gov/pubmed/34917633
http://dx.doi.org/10.3389/fmed.2021.758405

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8669506/
https://www.ncbi.nlm.nih.gov/pubmed/34917633
http://dx.doi.org/10.3389/fmed.2021.758405

Ejemplares similares